Loading
Latest filing published 17 Sept 2019 for Arcadia Biosciences, Inc., €27k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Kevin Comcowich discloses dealings in Arcadia Biosciences, Inc. to SEC (Form 4). Between 10 September 2019 and 17 September 2019, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (3 purchases, €115k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €29k and half below.
The newest entry dates from 17 September 2019: an open-market purchase of €27k, in Arcadia Biosciences, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations